Report overview

The report describes a 23% increase in revenue to £3.38m, driven by TMT reagents and related royalties. It highlights the consolidation of laboratory equipment and capabilities, the relocation of headquarters, and a leaner operating model. The company also reports Good Clinical Laboratory Practice accreditation and ISO 9001 recertification, while continuing to develop its proteomic services and research activities.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2017
Period: 1 January 2017 – 31 December 2017
Publication date: 23 April 2018
Language
Pages
File size

Standards & Assurance

No standards or assurance data is available for this report.

ESG & Materiality

ESG data

Indicators available in this report:

Employees

No materiality data is available for this report.

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services

Report overview

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2017
Period: 1 January 2017 – 31 December 2017
Publication date: 23 April 2018
Language
Pages
File size

Standards & Assurance

No standards or assurance data is available for this report.

ESG & Materiality

ESG data

Indicators available in this report:

Employees

No materiality data is available for this report.

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services

Report and Financial Statements

Report overview

Document

Standards & Assurance

ESG & Materiality

ESG data

Build your research dataset.

Report and Financial Statements

Report overview

Document

Standards & Assurance

ESG & Materiality

ESG data

Build your research dataset.